Marina P. Goncalves
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: February 09, 2026
Erratum: A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.
Journal: iScience
Published: October 31, 2025
Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer's disease.
Journal: Molecular neurodegeneration
Published: September 17, 2025
APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individuals.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 30, 2025
Glia inflammation and cell death pathways drive disease progression in preclinical and early AD.
Journal: EMBO molecular medicine
Published: June 17, 2025
ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumors.
Journal: Stem cell research & therapy
Published: January 24, 2025
A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.
Journal: iScience
Published: November 14, 2024
Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapy.
Journal: iScience
Published: October 28, 2024
Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth.
Journal: Journal of translational medicine
Published: February 11, 2024
A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses.
Journal: iScience
Published: October 10, 2023
Last Updated: 09/26/2026